Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. by Chubb, D, Broderick, P, Dobbins, SE, Frampton, M, Kinnersley, B, Penegar, S, Price, A, Ma, YP, Sherborne, AL, Palles, C, Timofeeva, MN, Bishop, DT, Dunlop, MG, Tomlinson, I, Houlston, RS

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients by Shah, V, Sherborne, AL, Johnson, DC, Ellis, S, Price, A, Chowdhury, F, Kendall, J, Jenner, MW, Drayson, MT, Owen, RG, Gregory, WM, Morgan, GJ, Davies, FE, Cook, G, Cairns, DA, Houlston, RS, Jackson, G, Kaiser, MF, NCRI Haematology Clinical Studies Group